Long-term (52-week) efficacy and safety of ipragliflozin add-on therapy to insulin in Japanese patients with type 1 diabetes mellitus: An uncontrolled, open-label extension of a phase III study
| Image |  |
|---|---|
| Description | scientific article published on 19 November 2019 |
| Author/s |
author: Kohei Kaku |
| Publication date | November 19, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |